Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice

scientific article

Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2337/DIABETES.52.1.21
P698PubMed publication ID12502489
P5875ResearchGate publication ID10972097

P2093author name stringRebecca J Gum
Jill E Clampit
James M Trevillyan
Roger G Ulrich
Cristina M Rondinone
Bradley A Zinker
Lori L Gaede
Matthew Heindel
Michael R Jirousek
Sandra L Koterski
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectpreproinsulinQ7240673
P304page(s)21-28
P577publication date2003-01-01
P1433published inDiabetesQ895262
P1476titleReduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice
P478volume52

Reverse relations

cites work (P2860)
Q36421324A high-selenium diet induces insulin resistance in gestating rats and their offspring
Q47273752A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway
Q36379383Adipose targets for obesity drug development
Q24304908An enzyme-linked immunosorbent assay to measure insulin receptor dephosphorylation by PTP1B
Q42976084Antidiabetic effects of bitter gourd extracts in insulin-resistant db/db mice
Q42972035Antidiabetic effects of total flavonoids from Litsea Coreana leve on fat-fed, streptozotocin-induced type 2 diabetic rats
Q37199333Beyond insulin replacement: addressing the additional needs of the diabetes patient
Q91832177Caulerpa lentillifera inhibits protein-tyrosine phosphatase 1B and protects pancreatic beta cell via its insulin mimetic effect
Q42224366Chromium-containing traditional Chinese medicine, Tianmai Xiaoke Tablet improves blood glucose through activating insulin-signaling pathway and inhibiting PTP1B and PCK2 in diabetic rats
Q28594157Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP
Q73210876Current literature in diabetes
Q34577123Dephosphorylation by default, a potential mechanism for regulation of insulin receptor substrate-1/2, Akt, and ERK1/2.
Q42924743Design, synthesis and docking studies on phenoxy-3-piperazin-1-yl-propan-2-ol derivatives as protein tyrosine phosphatase 1B inhibitors
Q33557864Discovery of novel PTP1B inhibitors with antihyperglycemic activity
Q37332419Dual ablation of Grb10 and Grb14 in mice reveals their combined role in regulation of insulin signaling and glucose homeostasis
Q51359048Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice.
Q42085317GSK-3β inhibition protects mesothelial cells during experimental peritoneal dialysis through upregulation of the heat shock response
Q42063971GSK3beta Inhibitor Peptide Protects Mice from LPS-induced Endotoxin Shock
Q33812730GSK3beta: role in therapeutic landscape and development of modulators
Q34496413High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism
Q37852704IRS2 and PTP1B: Two opposite modulators of hepatic insulin signalling.
Q43291838Impact of selenite and selenate on differentially expressed genes in rat liver examined by microarray analysis
Q34107651Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice
Q37001171Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age
Q50854047Inducible liver-specific knockdown of protein tyrosine phosphatase 1B improves glucose and lipid homeostasis in adult mice.
Q43193940Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice
Q42826975Inhibition of protein tyrosine phosphatase 1B and regulation of insulin signalling markers by caffeoyl derivatives of chicory ( Cichorium intybus) salad leaves
Q33707592Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue
Q30468589Insulin receptor substrate 2 (IRS2)-deficient mice show sensorineural hearing loss that is delayed by concomitant protein tyrosine phosphatase 1B (PTP1B) loss of function
Q37715179Insulin signaling meets mitochondria in metabolism
Q42503440Liver X receptor agonists ameliorate TNFalpha-induced insulin resistance in murine brown adipocytes by downregulating protein tyrosine phosphatase-1B gene expression
Q45256105Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B-/-mice
Q89811716Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence
Q34031701Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training
Q38593252Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction.
Q41500970Molecular docking and virtual screening for novel protein tyrosine phosphatase 1B (PTP1B) inhibitors
Q35126070Multiple low-dose radiation prevents type 2 diabetes-induced renal damage through attenuation of dyslipidemia and insulin resistance and subsequent renal inflammation and oxidative stress
Q47329751Neuronal PTP1B regulates body weight, adiposity and leptin action.
Q41818058Neuronal protein tyrosine phosphatase 1B deficiency results in inhibition of hypothalamic AMPK and isoform-specific activation of AMPK in peripheral tissues
Q39594207New emerging role of protein-tyrosine phosphatase 1B in the regulation of glycogen metabolism in basal and TNF-α-induced insulin-resistant conditions in an immortalised muscle cell line isolated from mice.
Q43299789New mechanisms by which physical exercise improves insulin resistance in the skeletal muscle
Q88197309Norathyriol reverses obesity- and high-fat-diet-induced insulin resistance in mice through inhibition of PTP1B
Q38259507Novel therapeutics for type 2 diabetes: insulin resistance
Q48171497Omentectomy Prevents Metabolic Syndrome By Reducing Appetite and Body Weight In A Diet-Induced Obesity Rat Model
Q37992232PTP1B and TCPTP--nonredundant phosphatases in insulin signaling and glucose homeostasis
Q37485003Peripheral nervous system insulin resistance in ob/ob mice.
Q38723618Promising Inhibitory Effects of Anthraquinones, Naphthopyrone, and Naphthalene Glycosides, from Cassia obtusifolia on α-Glucosidase and Human Protein Tyrosine Phosphatases 1B.
Q37614594Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer's Therapy?
Q36662772Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo
Q40177903Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance
Q36003873Protein-tyrosine phosphatases are involved in interferon resistance associated with insulin resistance in HepG2 cells and obese mice
Q35688217Recent advances in protein tyrosine phosphatase 1B inhibitors
Q40127873Redox-dependent and ligand-independent trans-activation of insulin receptor by globular adiponectin
Q38303815Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese mice
Q35049153Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats
Q54378456Rosiglitazone attenuates tumor necrosis factor-α-induced protein-tyrosine phosphatase-1B production in HepG2 cells.
Q38937256Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
Q27652187Structure-based optimization of protein tyrosine phosphatase-1 B inhibitors: capturing interactions with arginine 24
Q37653296Sustained high protein-tyrosine phosphatase 1B activity in the sperm of obese males impairs the sperm acrosome reaction
Q45255796Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors
Q34162283Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases
Q39119938Targeting density-enhanced phosphatase-1 (DEP-1) with antisense oligonucleotides improves the metabolic phenotype in high-fat diet-fed mice
Q52549011Telomerase - strategies to exploit an important chemotherapeutic target.
Q28587753The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
Q35143897The potential of antisense as a CNS therapeutic
Q37805797Tissue specificity on insulin action and resistance: past to recent mechanisms.
Q44805566Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action
Q36806514Treating insulin resistance: future prospects.
Q52338593Ursolic Acid Hydrazide Based Organometallic Complexes: Synthesis, Characterization, Antibacterial, Antioxidant, and Docking Studies.
Q35151318Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants

Search more.